drugset

drugset / Trial / NCT01142323

Pilot Study of Fenofibrate for PSC

NCT01142323 ↗

Phase 1/2 Terminated 8 enrolled University of Miami University of Florida · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether fenofibrate is safe and effective in the treatment primary sclerosing cholangitis (PSC).

Timeline

Start: 2010-10
Primary completion: 2012-12
Completion: 2012-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fenofibrate	Small molecule	160 mg	Oral

Indications